Advertisement

Experimental Drug Found to Reduce Two Signature Characteristics of Autism in Mice

by Kathy Jones on  April 30, 2012 at 6:44 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Researchers testing the effects of an experimental drug GRN-529 in a group of mice exhibiting autism-like behavior have found that the drug reduces two major characteristics, repetitive behavior and abnormal social interactions, associated with the condition.
 Experimental Drug Found to Reduce Two Signature Characteristics of Autism in Mice
Experimental Drug Found to Reduce Two Signature Characteristics of Autism in Mice

Crawley's team found that BTBR mice injected with GRN-529 showed reduced levels of repetitive self-grooming and spent more time around - and sniffing nose-to-nose with - a strange mouse.

Moreover, GRN-529 almost completely stopped repetitive jumping in another strain of mice.

"These inbred strains of mice are similar, behaviorally, to individuals with autism for whom the responsible genetic factors are unknown, which accounts for about three fourths of people with the disorders," noted Crawley. "Given the high costs - monetary and emotional - to families, schools, and health care systems, we are hopeful that this line of studies may help meet the need for medications that treat core symptoms."



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Autism Signature Drug Toxicity Rett Syndrome Acquired Epileptiform Aphasia 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Advertisement

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive